TNM classification of prostate tumours
TNM classification of prostate tumours
Prostate
(ICD-0 C61)
Rules for classification
The classification applies only to adenocarcinomas. Transitional cell carcinoma of the prostate is classified as a urethral tumour (see UICC TNM Classification of Malignant Tumours, sixth edition1, page 203). There should be a histological confirmation of the disease.
The following are the procedures for assessing T, N and M categories:
- T categories Physical examination, imaging, endoscopy, biopsy and biochemical tests
- N categories Physical examination and imaging
- M categories Physical examination, imaging, skeletal studies, and biochemical tests
Regional lymph nodes
The regional lymph nodes are the nodes of the true pelvis, which are essentially the pelvic nodes below the bifurcation of the common iliac arteries. Laterality does not affect the N classification.
TNM clinical classification*
T | Primary tumour | |
---|---|---|
TX | Primary tumour cannot be assessed | |
T0 | No evidence of primary tumour | |
T1 | Clinically inapparent tumour not palpable or visible by imaging | |
T1a | Tumour incident histological finding in 5% or less of tissue resected | |
T1b | Tumour incident histological finding in more than 5% of tissue retracted | |
T1c | Tumour identified by needle biopsy (eg because of elevated PSA) | |
T2 | Tumour confined within prostate# | |
T2a | Tumour involves one half of one lobe or less | |
T2b | Tumour involves more than half of one lobe, but not both lobes | |
T2c | Tumour involves both lobes | |
T3 | Tumour extends through the prostatic capsule^ | |
T3a | Extracapsular extension (unilateral or bilateral) | |
T3b | Tumour invades seminal vesicles(s) | |
T4 | Tumour is fixed or invades adjacent structures other than seminal vesicles: bladder neck,
external sphincter, rectum, levator muscles, or pelvic wall |
Notes:
- # Tumour found in one or both lobes by needle boipsy, but not palpable or visible by imaging, is classified as T1c.
- ^ Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3, but as T2.
N | Regional lymph nodes | |
---|---|---|
NX | Regional lymph nodes cannot be assessed | |
N0 | No regional lymph nodes metastasis | |
N1 | Regional lymph node metastasis |
Notes:
- Metastasis no larger than 0.2cm can be designated as pN1mi. (see Introduction, pN, page 10.)[1]
M | Distant metastasis | |
---|---|---|
MX | Distant metastasis cannot be assessed | |
M0 | No distant metastasis | |
M1 | distant metastasis | |
M1a | Non-regional lymph nodes(s) | |
M1b | Bone(s) | |
M1c | Other site(s) |
pTNM Pathological classification
The pT, pN, and pM categories correspond to the T, N, and M categories.
However, there is no pT1 category because there is insufficient tissue to assess the highest pT category.
G Histopathological grading
GX | Grade cannot be assessed |
G1 | Well differentiated (slight anaplasia) (Gleason 2-4) |
G2 | Moderately differentiated (moderate anaplasia) (Gleason 5-6) |
G3-4 | Poorly differentiated/undifferentiated (marked anaplasia) (Gleason 7-10) |
Stage grouping
Stage I | T1a | N0 | M0 | G1 |
Stage II | T1a | N0 | M0 | G2,3-4 |
T1b,c | N0 | M0 | Any G | |
T1,T2 | N0 | M0 | Any G | |
Stage III | T3 | N0 | M0 | Any G |
Stage IV | T4 | N0 | M09 | Any G |
Any T | N1 | M0 | Any G | |
Any T | Any N | M1 | Any G |
Summary
Prostate | |
---|---|
T1 | Not Palpable |
:T1a | <5% |
:T1b | >5% |
:T1c | Needle biopsy |
T2 | Confined within prostate |
:T2a | <half one lobe |
:T2b | >half one lobe |
:T2c | both lobes |
T3 | Through prostatic capsule |
:T3a | extracapsular |
:T3b | seminal vesicle(s) |
T4 | Fixed or invades adjacent structures: bladder neck, external sphincter, rectum, levator, muscles, pelvic wall |
N1 | Regional lymph node(s) |
M1a | Non-regional lymph node(s) |
M1b | Bone(s) |
M1c | Other site(s) |
*Since these guidelines have been developed the UICC have published the seventh edition of TNM Classification of Malignant Tumours.[2] There is no material difference in the definition of the T-, N-, and M-categories, however, there are some differences in stage grouping and risk grouping. See the table below:
T1 Not palpable or visible
T1a <5% or less T1b >5% T1c Detected by needle biopsy
T2 Confined within prostate T2a < half of one lobe T2b > half of one lobe T2c Both lobes
T3 Through prostate capsule T3a Extracapsular T3b Seminal vesicle(s)
T4 Fixed or invades adjacent structures No change from 6th
|
STAGE GROUPING (ANATOMIC) (UICC)
Stage I T1, T2a N0 Stage II T2b-2c N0 Stage III T3 N0 Stage IV T4 N0 Any T N1 Any T Any N M1
Change from 6th
Grade was in 6th
|
PROGNOSTIC GROUPING
I T1a – c N0 PSA <10 Gle < 6
T2a N0 PSA <10 Gle < 6
IIA T1 a – c N0 PSA < 20 Gle 7 T1 a – c N0 PSA >10 <20 Gle <6 T2a,b N0 PSA >10 < 20 Gle < 7
If PSA or Gleason is missing, use whatever is available |
IIB T2c N0 Any PSA Any Gle
T 1-2 N0 PSA >20 Any Gle T 1-2 N0 Any PSA Gle > 8
III T3a-c N0 Any PSA Any Gle IV T4 N0 Any PSA Any Gle Any T N1 Any PSA Any Gle Any T Any N M1 Any PSA Any Gle
If both missing, no prognostic grouping is possible |
References
- ↑ Sobin Lh, Wikkekind C. TNM Classification of Malignant Tumours.Sixth edition. UICC International Union Against Cancer. New York: Wiley-Liss 2002 Jan 1;184-187.
- ↑ Sobin LH, Gospodarowicz M, Wittekind C. TNM classification of Malignant Tumours. Seventh Edition. UICC International Union Against Cancer. New York: Wiley-Blackwell 2009 Jan 1.